Why the study?
Due to the clinical complexity and heterogeneity of desmin-related cardiomyopathies, in vitro cellular models are essential tools to investigate disease mechanisms, prompting an overview of the advantages and limitations of available non-human and human-based platforms.
Population
In vitro non-human and human-based cellular models of desmin-related cardiomyopathies
Design
Review
Answers are grounded in this paper and cite their sources.
DES mutations underlie heterogeneous cardiomyopathies; leaves open targeted therapies for desmin aggregation.
Desmin (DES) is an intermediate filament protein essential for cardiomyocyte structural integrity, mechanical coupling, and intracellular organization. Mutations in the DES gene cause a spectrum of inherited disorders collectively known as desmin‐related cardiomyopathies (DRC), characterized by protein aggregation, cytoskeletal disorganization, and progressive cardiac dysfunction. Clinically, DRC encompasses heterogeneous phenotypes including dilated, arrhythmogenic, and restrictive cardiomyopathies. The pathophysiology of DRC involves impaired filament assembly, mitochondrial dysfunction, altered autophagy, and metabolic dysregulation, contributing to mechanical instability and electrical disturbances. Due to the complexity and heterogeneity of these conditions, in vitro cellular models have become essential tools to investigate disease mechanisms. This review provides an overview of available cellular models for DRC, including non‐human systems and human‐based platforms. We discuss the specific advantages of each model for studying DES aggregation, cytoskeletal defects, and mutation‐specific effects, while highlighting limitations in terms of physiological relevance and translational applicability. We present emerging approaches, including patient‐specific iPSC models and multicellular/3D systems, which better recapitulate human cardiac pathology, enabling more precise disease modelling. Nonetheless, significant gaps remain in understanding genotype–phenotype correlations and the contribution of disease modifiers. Future developments of advanced cellular models will be crucial to unravel DRC pathogenesis and support the development of targeted therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Iengo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: